Establishes QSYMIA as one of the most affordable branded weight-management options available in the United States— Effective immediately, ...

Oral GLP-1s for obesity can differ from injectables — including in their effectiveness and dosing. Here's why pills aren’t always more convenient than injections.

Spread the loveImagine a drug so powerful it promises weight loss comparable to bariatric surgery, shedding a staggering 30% ...

There is no universal answer to which weight loss drug works the fastest, as individual responses vary. However, some general ...

Share on Pinterest A new analysis found that the diabetes medication orforglipron (Foundayo), an oral GLP-1, helped women lose weight regardless of their menopausal status. Healthline/Photo by Eli ...

LONDON, Sept 22 - Weight-loss pills could capture as much as half of the global obesity drug market by 2030, Novo Nordisk's chief executive told Reuters on Tuesday, as the Danish drugmaker positions ...

An emerging class of weight-loss medications helps users shed pounds but with a much lower risk for gastrointestinal side effects compared to popular GLP-1s, researchers report. The weekly injected ...

The FDA has warned a major compounding pharmacy that it violated federal law by making copies of blockbuster weight-loss drugs in "inordinate amounts." ...

The weight loss drugs landscape in the UK underwent a seismic shift on 6 July 2026 when Wegovy – an injectable semaglutide – became the first GLP-1 available to buy as a daily pill. Wegovy was ...

Add Yahoo as a preferred source to see more of our stories on Google. A blister pack containing Wegovy (semaglutide) tablets on a line in Novo Nordisk’s facility in Malov, west of Copenhagen, Denmark, ...

obesity, with a phase 2 trial finding that the amylin analogue petrelintide reduced body weight by up to 10.7% through week 42, according to a study ...

LONDON, Sept 22 - Weight-loss pills could capture as much as half of the global obesity drug market by 2030, Novo Nordisk's (NOVOb.CO), opens new tab chief ‌executive told Reuters on Tuesday, as the ...